Ibs Infoweb Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 66.26%
- Profit Growth 136.12%
- Ebitda 136.03%
- Net Worth 24.29%
- Total Assets 24.31%
About Ibs Infoweb
Ibs Infoweb Private Limited (IIPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 March 2011 and has a history of 13 years and ten months. Its registered office is in Lucknow, Uttar Pradesh, India.
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Pramod Srivastava, Shishir Chaudhari, Shivendra Srivastava, and One other member serve as directors at the Company.
Company Details
-
Location
Lucknow, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2011PTC043963
-
Company No.
043963
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Mar 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Ibs Infoweb?
Board Members (4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pramod Srivastava | Director | 14-Mar-2011 | Current |
Shishir Chaudhari | Director | 14-Mar-2011 | Current |
Shivendra Srivastava | Additional Director | 25-Mar-2020 | Current |
Harendra Yadav | Additional Director | 25-Mar-2020 | Current |
Financial Performance of Ibs Infoweb.
Ibs Infoweb Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 66.26% increase. The company also saw a substantial improvement in profitability, with a 136.12% increase in profit. The company's net worth Soared by an impressive increase of 24.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
|
||||||
Revenue from Operations |
|
||||||
Total Assets |
|
||||||
Profit or Loss |
|
||||||
Net Worth |
|
||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Ibs Infoweb?
Unlock access to Ibs Infoweb's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ibs Infoweb?
Ibs Infoweb has a workforce of 31 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ibs Infoweb, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ibs Infoweb's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.